Ascension sells Arizona Medicaid plan stake to Aetna
The deal lets Ascension offload insurance risk while giving Aetna a share of a profitable dual-eligible plan.
Ascension has sold its ownership in an Arizona Medicaid managed-care plan to Aetna, according to Healthcare Dive. The transaction allows the Catholic health system to shed insurance risk associated with operating the plan.
For Aetna, the purchase provides a stake in a profitable plan that serves dual-eligible members — those enrolled in both Medicare and Medicaid. These members are often seen as high-margin for insurers, making the plan an attractive asset.
The sale highlights a broader shift in which health systems retreat from insurance operations while payers expand into government-backed programs. Ascension reduces its financial exposure, and Aetna strengthens its presence in the Arizona Medicaid market.
More in Medicine & Biotech
Ebola Vaccine Trial Launches in DR Congo Outbreak Zone
Health workers in DR Congo have begun testing whether a vaccine designed for a different Ebola strain can protect against the current outbreak.
Beacon Gene Therapy for Rare Vision Loss Succeeds in Pivotal Trial
A pivotal trial of Beacon Therapeutics' gene therapy for X-linked retinitis pigmentosa improved visual acuity, clearing the path toward an FDA submission.
Alkermes orexin agonist shows early promise for ADHD
Early-stage data suggest Alkermes' orexin agonist could expand the drug class beyond sleep disorders into ADHD.
Telix to Buy ITM for $1.65B, Challenging Novartis in Radiopharma
The acquisition gives Telix a late-stage pipeline and supply network that could compete with Novartis' Lutathera.